Los Angeles, CA, United States of America

Mohamad Navab

This inventor holds 22 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Therapeutic Peptides. Top assignees: University of California, The UAB Research Foundation (The University of Alabama at Birmingham), The University of Alabama. Active years: 2003-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohamad Navab. Retrieved from https://idiyas.com/inventor/mohamad-navab

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22 

% Patents Active = 36.4

 

 

Average Co-Inventor Count = 2.8

ph-index = 11

Forward Citations = 299(Granted Patents)


Location History:

  • Los Angles, CA (US) (2006 - 2011)
  • Los Angeles, CA (US) (2003 - 2021)

Company Filing History:


Years Active: 2003-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Peptide Mimetics
ApoA-I Peptides
Eye Disease Treatment
Statin Activity
Inflammatory Response
Scleroderma
Atherosclerosis
Oral Delivery
High-Density Lipoprotein
Genetic Engineering
Salicylanilides
Peptide Synergy
22 patents (USPTO):Explore Patents

Title: Innovative Contributions of Mohamad Navab in Biotechnology

Introduction

Mohamad Navab is a prominent inventor based in Los Angeles, CA, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 22 patents, he has made groundbreaking advancements that aim to enhance human health through innovative treatments and solutions.

Latest Patents

Among his notable inventions, two recent patents stand out. The first is titled "Ezetimibe-associated ApoA-I mimetic peptides showing enhanced synergism." This invention provides various embodiments of apoA-I mimetic peptides that demonstrate improved synergistic activity when combined with ezetimibe in vivo. A key component in this invention is the transgenic 6F peptide, referred to as the Ez-T6F peptide. The patent also details methods for synthesizing these peptides, including incubation processes with different solvents to produce a dry ezetimibe-associated apoA-I mimetic peptide.

The second patent, "Modulating disease through genetic engineering of plants," focuses on transgenic plants, such as tomatoes, that express specific peptides with biological activities beneficial to mammalian health. These peptides are designed to lower SAA, increase paroxonase activity, and improve the HDL inflammatory index when consumed.

Career Highlights

Mohamad Navab's career highlights include his affiliation with the University of California and The UAB Research Foundation. His work at these esteemed institutions has played a significant role in advancing research and development in biotechnology.

Collaborations

Throughout his career, Mohamad has collaborated with esteemed colleagues, including Alan M. Fogelman and Gattadahalli M. Anantharamaiah. Together, they have contributed to the understanding and development of novel therapies aimed at improving cardiovascular health and addressing metabolic diseases.

Conclusion

In summary, Mohamad Navab is a highly innovative inventor whose work in biotechnology is making a profound impact on health solutions. His patents not only reflect his expertise and dedication but also his commitment to advancing science and improving lives through innovative approaches. His future contributions are anticipated to continue shaping the landscape of medical treatments and research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…